Spyros N Deftereos (Spyros Deftereos)

Publication Activity (10 Years)

Years Active: 2018-2024
Publications (10 Years): 5

Top Topics

Systematic Review

Multiple Sclerosis

Top Venues

Current pharmaceutical design

Journal of central nervous system disease

This page only lists publications with an associated author ORCID identifier.

Publications

Spyros N Deftereos, George D Vavougios, Christos Bakirtzis, George Hadjigeorgiou, Nikolaos Grigoriadis
Effects of High Efficacy Multiple Sclerosis Disease Modifying Drugs on the Immune Synapse: A Systematic Review. Current pharmaceutical design 30 (7) (2024)
Spyros N Deftereos, George D Vavougios, Christos Bakirtzis, George Hadjigeorgiou, Nikolaos Grigoriadis
Effects of High Efficacy Multiple Sclerosis Disease Modifying Drugs on the Immune Synapse: A Systematic Review. Current pharmaceutical design 30 (7) (2024)
Spyros N Deftereos, George D Vavougios, Christos Bakirtzis, George Hadjigeorgiou, Nikolaos Grigoriadis
Effects of High Efficacy Multiple Sclerosis Disease Modifying Drugs on the Immune Synapse: A Systematic Review. Current pharmaceutical design (2024)
Georgios Tsivgoulis, Spyros N Deftereos, Claudio Gobbi, Elisabeth Gulowsen Celius, Alina Kulakowska, Giorgia Maniscalco, Irene Mendes, Nicolaos Grigoriadis
Oral Cladribine in Patients who Change From First-Line Disease Modifying Treatments for Multiple Sclerosis: Protocol of a Prospective Effectiveness and Safety Study (CLAD CROSS). Journal of central nervous system disease 14 (2022)
Spyros N Deftereos, Evangelos Koutlas, Efrosini Koutsouraki, Athanassios Kyritsis, Panagiotis Papathanassopoulos, Nikolaos Fakas, Vaia Tsimourtou, Nikolaos Vlaikidis, Antonios Tavernarakis, Konstantinos Voumvourakis, Michalis Arvanitis, Dimitrios Sakellariou, Filippo DeLorenzo
Seasonal adherence to, and effectiveness of, subcutaneous interferon β-1a administered by RebiSmart® in patients with relapsing multiple sclerosis: results of the 1-year, observational GEPAT-SMART study. BMC neurology 18 (1) (2018)